FDA investigates Abbott infant formula after reports of illness and one death
date:Feb 23, 2022
The US, Canada, Australia and China are sending out warnings to the public over Abbott infant formula products after the US Food and Drug Administration (FDA) announced it was investigating four consumer complaints of Cronobacter sakazakii and Salmonella Newport infections.

All four cases related to these complaints were hospitalized, and Cronobacter may have contributed to a death in one case, the FDA says.

The investigation so far has been associated with three Cronobacter illnesses and one

04/20 22:25